These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17004016)

  • 1. Sequential screening for diabetes--evaluation of a campaign in Swiss community pharmacies.
    Hersberger KE; Botomino A; Mancini M; Bruppacher R
    Pharm World Sci; 2006 Jun; 28(3):171-9. PubMed ID: 17004016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with a colorectal cancer campaign in Swiss pharmacies.
    Ruggli M; Stebler D; Gasteiger M; Trottmann M; Hochuli P; Telser H; Vaucher F
    Int J Clin Pharm; 2019 Oct; 41(5):1359-1364. PubMed ID: 31564044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the Activities of Community Pharmacies during the Annual Campaign with Focus on Diabetes Prevention].
    Schmiedel K; Friedland K; Schlager H
    Gesundheitswesen; 2016 Oct; 78(10):678-680. PubMed ID: 26551848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
    Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
    BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifestyle changes for prehypertension with other cardiovascular risk factors: findings from Thailand.
    Pongwecharak J; Treeranurat T
    J Am Pharm Assoc (2003); 2011; 51(6):719-26. PubMed ID: 22068193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes care in Norwegian pharmacies: a descriptive study.
    Kjome RL; Sandberg S; Granås AG
    Pharm World Sci; 2008 Apr; 30(2):191-8. PubMed ID: 17891470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change of body weight and lifestyle of persons at risk for diabetes after screening and counselling in pharmacies.
    Botomino A; Bruppacher R; Krähenbühl S; Hersberger KE
    Pharm World Sci; 2008 Jun; 30(3):222-6. PubMed ID: 18046620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Know your diabetes risk project: Student pharmacists educating adults about diabetes risk in a community pharmacy setting.
    Letassy N; Dennis V; Lyons TJ; Harrison D; Burton M; Kirkpatrick A
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):188-94. PubMed ID: 20199961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for sleep disorders in community pharmacies--evaluation of a campaign in Switzerland.
    Hersberger KE; Renggli VP; Nirkko AC; Mathis J; Schwegler K; Bloch KE
    J Clin Pharm Ther; 2006 Feb; 31(1):35-41. PubMed ID: 16476118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic screening and health promotion for type 2 diabetes: an expanding public health role for the community pharmacist.
    Dhippayom T; Fuangchan A; Tunpichart S; Chaiyakunapruk N
    J Public Health (Oxf); 2013 Jun; 35(2):262-9. PubMed ID: 22976588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO).
    Fornos-Pérez JA; Andrés-Rodríguez NF; Andrés-Iglesias JC; Luna-Cano R; García-Soidán J; Lorenzo-Veiga B; Mera-Gallego R; García-Riestra R
    Endocrinol Nutr; 2016 Oct; 63(8):387-96. PubMed ID: 27481442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes prevalence and metabolic risk profile in an unselected population visiting pharmacies in Switzerland.
    Rey A; Thoenes M; Fimmers R; Meier CA; Bramlage P
    Vasc Health Risk Manag; 2012; 8():541-7. PubMed ID: 23049259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rural community pharmacy: a feasible site for a health promotion and screening service for cardiovascular risk factors.
    Hourihan F; Krass I; Chen T
    Aust J Rural Health; 2003 Jan; 11(1):28-35. PubMed ID: 12603444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk screening program in Australian community pharmacies.
    Peterson GM; Fitzmaurice KD; Kruup H; Jackson SL; Rasiah RL
    Pharm World Sci; 2010 Jun; 32(3):373-80. PubMed ID: 20217476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis screening and education in community pharmacies using a team approach.
    MacLaughlin EJ; MacLaughlin AA; Snella KA; Winston TS; Fike DS; Raehl CR
    Pharmacotherapy; 2005 Mar; 25(3):379-86. PubMed ID: 15843285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
    Krass I; Mitchell B; Clarke P; Brillant M; Dienaar R; Hughes J; Lau P; Peterson G; Stewart K; Taylor S; Wilkinson J; Armour C
    Diabetes Res Clin Pract; 2007 Mar; 75(3):339-47. PubMed ID: 16884811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals.
    Snella KA; Canales AE; Irons BK; Sleeper-Irons RB; Villarreal MC; Levi-Derrick VE; Greene RS; Jolly JL; Nelson AA
    J Am Pharm Assoc (2003); 2006; 46(3):370-7. PubMed ID: 16739759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects.
    Mangum SA; Kraenow KR; Narducci WA
    J Am Pharm Assoc (Wash); 2003; 43(1):50-5. PubMed ID: 12585751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone health screening, education, and referral project in northwest Iowa: creating a model for community pharmacies.
    Johnson JF; Koenigsfeld C; Hughell L; Parsa RA; Bravard S
    J Am Pharm Assoc (2003); 2008; 48(3):379-87. PubMed ID: 18595823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.